People – Page 2870 – I wish I had more to offer

Millwright Holdings Promotes Laura Murphy to President of Bolt PR Following Record-Breaking Year

NEW YORK, Jan. 22, 2025 /PRNewswire/ — Millwright Holdings is pleased to announce the promotion of Laura Murphy to President of Bolt PR, its award-winning B2C public relations, content, and digital marketing agency serving clients across the hospitality, food and beverage, spirits, franchise, health and wellness, consumer products, consumer tech, as well as B2B tech verticals. Continue… Continue reading Millwright Holdings Promotes Laura Murphy to President of Bolt PR Following Record-Breaking Year

ASM CAPITAL GROUP LOOKS TO DOMINATE NEWLY DESIGNATED AMERICAN WHISKEY CATEGORY WITH FIRST AMERICAN SINGLE MALT-DEDICATED FUND

MIAMI, Jan. 22, 2025 /PRNewswire/ — Today, ASM Capital Group, a trailblazing, new spirits investment fund elevating the newly commissioned American Single Malt Whiskey (ASM) category on a global scale, marks the official category designation from The Alcohol and Tobacco Tax and Trade Bureau (TTB) with the announcement of the ASM Capital Whiskey Fund. The only fund… Continue reading ASM CAPITAL GROUP LOOKS TO DOMINATE NEWLY DESIGNATED AMERICAN WHISKEY CATEGORY WITH FIRST AMERICAN SINGLE MALT-DEDICATED FUND

Elegoo Unveils Saturn 4 Ultra 16K: A Major Leap in Accuracy and User Experience

SHENZHEN, China, Jan. 22, 2025 /PRNewswire/ — Elegoo, a rapidly developing brand in global smart manufacturing, announces today the launch of the Saturn 4 Ultra 16K, the latest addition to its line of advanced resin 3D printers. This new model builds on the success of the original Saturn 4 Ultra, Elegoo’s best-selling resin printer of 2024,… Continue reading Elegoo Unveils Saturn 4 Ultra 16K: A Major Leap in Accuracy and User Experience

Elegoo Unveils Saturn 4 Ultra 16K: A Major Leap in Accuracy and User Experience

Sen-Jam Pharmaceutical Secures Financial and Strategic Investment from 5 Horizons Capital to Advance SJP-001 Clinical Trial with Novotech

HUNTINGTON, N.Y., Jan. 22, 2025 /PRNewswire/ — Sen-Jam Pharmaceutical, a leader in innovative solutions targeting inflammation and metabolic health, proudly announces a financial and strategic investment from 5 Horizons Capital. Horizon, as the lead investor for the Phase 2 clinical trial of SJP-001, Sen-Jam’s flagship therapeutic, is paving the way for innovation in collaboration with… Continue reading Sen-Jam Pharmaceutical Secures Financial and Strategic Investment from 5 Horizons Capital to Advance SJP-001 Clinical Trial with Novotech

Palo Alto Networks Prepares Organizations for Quantum Security with QRNG Open API

Consortium of innovators paves the way to make a quantum secure future accessible to all SANTA CLARA, Calif., Jan. 22, 2025 /PRNewswire/ — Palo Alto Networks (NASDAQ: PANW), the global cybersecurity leader, today announced the release of a Quantum Random Number Generator (QRNG) Open API framework, empowering organizations to prepare for future quantum security threats. The… Continue reading Palo Alto Networks Prepares Organizations for Quantum Security with QRNG Open API

Say Goodbye to Boring Interiors – Hernest’s Latest Designs Are Here to Dazzle

LOS ANGELES, Jan. 22, 2025 /PRNewswire/ — Hernest is delighted to introduce its exclusive new collection, a testament to the brand’s distinctive approach to modern furniture design. This carefully curated series features five exceptional pieces, each thoughtfully crafted to elevate the aesthetics and functionality of any space, from cozy living rooms to elegant dining areas.… Continue reading Say Goodbye to Boring Interiors – Hernest’s Latest Designs Are Here to Dazzle

AvaWatz Combines AI Innovation with Everyday Safety in New Investment Opportunity

DALLAS, Jan. 22, 2025 /PRNewswire/ — AvaWatz Company (“AvaWatz”), a trusted partner of U.S. Defense and Homeland Security and a leader in AI-driven autonomous systems is excited to announce the launch of a new equity crowdfunding campaign on Wefunder – https://wefunder.com/avawatz. Building on its mission-critical technologies and commercial successes, AvaWatz invites early supporters and new… Continue reading AvaWatz Combines AI Innovation with Everyday Safety in New Investment Opportunity

Artax Biopharma achieves clinical validation of first-in-class, oral, Nck modulator AX-158 for autoimmune disease in phase 2a study

Novel breakthrough: first molecule to modulate the fundamental mechanism of T cell activation underlying autoimmune pathology Statistically significant improvements in T cell and psoriasis-related biomarkers in line with PASI improvements in Phase 2a in patients with psoriasis Phase 2a confirms well-tolerated safety profile, with no infections or discontinuations CAMBRIDGE, Mass., Jan. 22, 2025 /PRNewswire/ — Artax… Continue reading Artax Biopharma achieves clinical validation of first-in-class, oral, Nck modulator AX-158 for autoimmune disease in phase 2a study

Rigel’s Fostamatinib Being Studied by National Institute of Health in Patients with Sickle Cell Disease

First patient enrolled in NIH/NHLBI-sponsored Phase 1 Study of fostamatinib, Rigel’s oral SYK inhibitor SOUTH SAN FRANCISCO, Calif., Jan. 22, 2025 /PRNewswire/ — Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the first patient has been enrolled in a Phase 1 study evaluating the safety and tolerability of escalating doses of fostamatinib, the company’s oral spleen tyrosine… Continue reading Rigel’s Fostamatinib Being Studied by National Institute of Health in Patients with Sickle Cell Disease